The US Food and Drug Administration has approved a new treatment for HIV-1 infection developed by ViiV Healthcare. Tivicay (dolutegravir) is an integrase strand transfer inhibitor to be used in combination with other antiretroviral drugs. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
